Corticosteroid therapy in transplant patients can lead to which condition?

Corticosteroid therapy in transplant patients can lead to which condition?

• A. Hyponatremia
• B. Hypernatremia
• C. Hypokalemia
• D. Hyperkalemia

Answer: (B)

Corticosteroid therapy in transplant patients can lead to hypernatremia due to the sodium-retaining effects of these medications. Corticosteroids stimulate the renal tubular reabsorption of sodium, which can result in increased sodium levels in the bloodstream. This retention can also promote fluid retention, potentially leading to an increase in blood pressure and the risk of complications associated with elevated sodium levels. It's important to monitor electrolyte levels in transplant patients receiving corticosteroid therapy, as maintaining electrolyte balance is crucial for overall patient health. The use of corticosteroids can result in significant hormonal and metabolic changes, influencing various laboratory results and necessitating careful management to prevent potential complications.

Corticosteroid therapy in transplant patients can lead to hypernatremia due to the sodium-retaining effects of these medications. Corticosteroids stimulate the renal tubular reabsorption of sodium, which can result in increased sodium levels in the bloodstream. This retention can also promote fluid retention, potentially leading to an increase in blood pressure and the risk of complications associated with elevated sodium levels.

It's important to monitor electrolyte levels in transplant patients receiving corticosteroid therapy, as maintaining electrolyte balance is crucial for overall patient health. The use of corticosteroids can result in significant hormonal and metabolic changes, influencing various laboratory results and necessitating careful management to prevent potential complications.